Intuitive Surgical Inc. (ISRG)
NASDAQ: ISRGHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ISRG stock chart
Technical analysisKey statistics
All statistics- Market cap
- $138.33B
- P/E (TTM)
- 48.25
- Forward P/E
- 32.00
- EPS (TTM)
- $8.27
- Dividend yield
- None
- 52-week range
- 328.57 – 603.88
- Day range
- 397.78 – 410.00
- Volume / Avg
- 2.69M / 2.34M
- Beta
- —
- Shares outstanding
- 346.64M
52-week range
ISRG stock today
Shares of Intuitive Surgical (ISRG) finished lower on Nov 20 at $399.05, a drop of 2.01% or $8.19 per share, versus the S&P 500's 3.70% decline. Shares are 33.9% below their 52-week high of $603.88, set on Jan 7, 2026 and 21.5% above the 52-week low of $328.57, in the middle of the past year's range. ISRG is down 29.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 28.9%.
At 48.3x trailing earnings, Intuitive Surgical trades above the peer-group median of 23.5x. Its forward P/E of 32.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Intuitive Surgical
Company profileIntuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. David J. Rosa
- Headquarters
- Sunnyvale, CA
- Employees
- 17,021
- IPO year
- 2000
- Website
- intuitive.com
Financial highlights
Full financialsIn fiscal 2025, Intuitive Surgical generated $10.06 billion in revenue, up 20.5% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $2.86 billion (+23.0% year over year), for a net margin of 28.4% versus a median of 25.2% in the prior 5 years. Gross margin was 66.0% (down from 67.5%) and operating margin 29.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $10.06B | $8.35B | $7.12B | $6.22B | $5.71B |
| Growth | +20.51% | +17.24% | +14.49% | +8.97% | +31.01% |
| Net income | $2.86B | $2.32B | $1.80B | $1.32B | $1.70B |
| EPS (diluted) | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 |
Analyst forecast
ForecastConsensus (34 analysts)
buy
Avg. price target
$486.57+21.93%
- Strong buy 7
- Buy 19
- Hold 6
- Sell 1
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 20, 2026
- EPS actual vs est.
- $2.53 vs $2.13
- Surprise
- +18.78%
ISRG news
All ISRG news- Here's Why You Should Retain Ecolab Stock in Your Portfolio NowNasdaqECL, ISRG, WST, GKOS
- GEHC Advances Manganese-Based MRI Agent to Phase 3 After Positive DataNasdaqGEHC, ISRG, WST, GKOS
- Hims & Hers Launches Peptides+ to Expand Personalized Health CareNasdaqHIMS, ISRG, WST, GKOS
- Buy 3 Medical Device Stocks for a Stable Portfolio With Solid UpsideNasdaqISRG, STE, PLSE
- GE HealthCare Wins FDA Nod for AI Feeding Tube Detection SoftwareNasdaqGEHC, ISRG, WST, GKOS
- Intuitive Surgical (ISRG) Down 1.7% Since Last Earnings Report: Can It Rebound?Nasdaq
- Here's Why You Should Retain NeuroPace Stock in Your Portfolio for NowNasdaqNPCE, ISRG, WST, GKOS
- Philips Unveils Skylight Device Manager to Boost Ultrasound EfficiencyNasdaqPHG, ISRG, WST, GKOS
Intuitive Surgical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EWEdwards Lifesciences Corporation | 101.85 | -1.95% | $58.56B | vs ISRG |
| STESTERIS plc (Ireland) | 255.76 | +0.39% | $24.84B | vs ISRG |
| ZBHZimmer Biomet Holdings Inc. | 101.10 | -0.36% | $19.13B | vs ISRG |
| MASMasco Corporation | 82.60 | -0.23% | $15.92B | vs ISRG |
| SNNSmith & Nephew SNATS Inc. | 29.83 | 0.00% | $12.47B | vs ISRG |
| ALGNAlign Technology Inc. | 155.17 | -2.82% | $10.94B | vs ISRG |
| AITApplied Industrial Technologies Inc. | 274.99 | -4.65% | $10.04B | vs ISRG |
| POOLPool Corporation | 208.23 | -0.70% | $7.44B | vs ISRG |
Indexes, lists and sector
Index membership
Intuitive Surgical stock FAQ
What is Intuitive Surgical's stock price today?
ISRG last traded at $399.05 as of Nov 20, 4:00 PM EST, down 2.01% on the day. Prices are delayed at least 15 minutes.
Does Intuitive Surgical pay a dividend?
No. Intuitive Surgical does not currently pay a regular cash dividend.
What is ISRG's P/E ratio?
ISRG trades at a trailing P/E ratio of 48.25 and a forward P/E of 32.00, compared with a median of 23.5 for its closest peers.
Is Intuitive Surgical in the S&P 500?
Yes. Intuitive Surgical (ISRG) is a constituent of the S&P 500 index.
Who is Intuitive Surgical's CEO?
Mr. David J. Rosa is the chief executive officer of Intuitive Surgical Inc., which has about 17,021 employees.
Has ISRG ever split its stock?
Yes. The most recent ISRG stock split was a 3-for-1 split on Oct 5, 2021, one of 3 splits on record.
What is the ISRG 52-week high?
The 52-week high for ISRG is $603.88 and the 52-week low is $328.57. The stock is currently 33.9% below its high.